What Counts as “Meaningful” Patient Engagement in Clinical Trials? A Global Glimpse at How It’s Measured

There was a time—and not that long ago—when patients were nothing more than subjects in medical research. Data points. Test cases. They were studied, but rarely asked what they thought. Now, that script is changing. Around the world, people with lived experience (PWLE) are being invited into research not just as participants, but as true partners. And in some cases, they’re leading it.

Increasingly, funders are requiring patient engagement. Not just checking a box, but truly shaping research questions, methods, ethics, and results. But that raises a big question: how do we know if engagement is “meaningful”? Who decides? And what does that look like from funder to funder, country to country?

Below, I walk through how some of the leading funders and national health agencies in the U.S., Canada, and Australia are defining and evaluating patient engagement in clinical trials. Some are doing more than others. But all are moving in the right direction.

1. PCORI (Patient-Centered Outcomes Research Institute – U.S.)

What They Expect: PCORI led the way nationally in embedding patient engagement into its funding model. As of 2024, PCORI introduced “Foundational Expectations for Partnerships in Research,” which outline six principles every funded project must follow. These include recruiting diverse voices, involving partners early and often, dedicating resources for engagement (including compensation), supporting capacity building, ensuring true decision-making power, and actively assessing and adjusting engagement efforts over time.

How It’s Assessed: Researchers must outline their engagement strategy from the beginning. Reviewers assess proposals based on the strength of those plans and the applicants’ track record. Final reports must detail how engagement shaped the project’s course and outcomes.

Why It Matters: PCORI is not just asking for inclusion, they’re asking for power-sharing. They’re also funding projects that study how engagement works and how to improve it.

2. CDMRP (Congressionally Directed Medical Research Programs – U.S. Department of Defense)

What They Expect: CDMRP brings patients and advocates directly into the peer review process. These “consumer reviewers” sit alongside scientists and have full voting rights when it comes to deciding what gets funded. Their charge is simple: bring the voice of lived experience into funding decisions.

How It’s Assessed Unlike PCORI, CDMRP doesn’t require patient engagement during the research project itself—but it deeply values the relevance and impact of the study from the start. If the proposal doesn’t connect with what matters to patients, it’s unlikely to move forward.

Why It Matters This is one of the clearest examples of democratizing science. When patients help decide what research gets funded, the entire system changes—often for the better.

3. VA (U.S. Department of Veterans Affairs)

What They Expect: The VA has been integrating Veteran Engagement Panels into many of its research initiatives, particularly in the areas of pain, mental health, and chronic conditions. These panels are made up of Veterans who work alongside researchers, providing ongoing guidance and insight.

How It’s Assessed: Proposals submitted to VA Health Services Research and Development must now include a Veteran Engagement Plan. The SERVE Toolkit is one of the VA’s best resources, offering step-by-step guidance on building and sustaining these partnerships.

Why It Matters: The VA is building a culture shift from within, giving Veterans a lasting role in the research that affects their lives. They’re not quite where PCORI is, but they’re making real progress.

4. NIH (National Institutes of Health – U.S.)

What They Expect: NIH’s efforts toward patient engagement efforts is a mixed bag. While traditional NIH grants typically do not require patient engagement, newer initiatives such as the HEAL Initiative, RECOVER, and All of Us place a strong emphasis on it. These programs call for community involvement in research design, recruitment, and dissemination.

How It’s Assessed: Some RFAs (Requests for Applications) now include scoring sections specifically related to engagement. Others encourage it. NIH has not yet rolled out a unified engagement rubric across all its funding mechanisms.

Why It Matters: NIH is moving slowly, but its major programs are beginning to model what good engagement looks like. The direction is promising, even if uneven.

5. SPOR (Strategy for Patient-Oriented Research – Canada)

What They Expect: SPOR, led by Canada’s CIHR, sets a high bar. They call for co-leadership by patients, not just consultation. Their Patient Engagement Framework highlights principles like inclusiveness, mutual respect, support, and co-building. In many cases, patients play a crucial role in determining research priorities, designing protocols, and evaluating results.

How It’s Assessed: CIHR integrates engagement into peer review. Metrics are being developed to evaluate how engagement affects both process and outcomes. Training and compensation for patient partners are considered essential.

Why It Matters: SPOR goes further than most in treating patients as collaborators, not add-ons. It’s one of the strongest models globally.

6. NHMRC and MRFF (Australia)

What They Expect: Australia’s health research agencies strongly recommend consumer and community involvement, although it’s not yet a universal requirement. Draft guidelines from NHMRC and MRFF point toward more structured expectations, with a focus on inclusion, relevance, and real-world value.

How It’s Assessed: Applications often include a consumer involvement section, and reviewers assess the quality and sincerity of the effort. National consultations are shaping how these expectations will become more formalized.

Why It Matters: Australia is catching up fast and may soon join Canada in setting an international standard for meaningful engagement.

Common Ground & Gaps

Where most of these funders agree:

Engagement should start early and last throughout the study.
Tokenism doesn’t cut it anymore.
Compensation, training, and shared power are crucial.

But real gaps remain:

No shared international standard
Many researchers still treat engagement as optional
The impact of engagement is rarely tracked or reported back to communities

What Needs to Happen Next

If we’re serious about making research more equitable and more relevant, we need to:

Establish international standards for meaningful engagement
Use real rubrics in grant review processes
Report annually on engagement outcomes
Build training, mentorship, and peer learning for both researchers and patient partners

Closing Thoughts

I’ve seen firsthand what happens when patient engagement is done right. The questions get better. The trials get stronger. The results matter more. But none of that happens by accident. It takes intention, structure, and accountability.

We have blueprints. Now we need to build systems that honor them.

Disclaimer
The views, positions, and recommendations expressed in this article are based on my personal experiences and independent research. They are solely my own and do not necessarily reflect the views, policies, or positions of the American Chronic Pain Association (ACPA).

Disclosure

This content was developed by the author with assistance from ChatGPT, an AI tool created by OpenAI. The AI was used for organizing ideas, drafting, and refining language. All final content reflects the author’s lived experience, independent analysis, and original perspective.

References

What Counts as “Meaningful” Patient Engagement in Clinical Trials? A Global Glimpse at How It’s Measured

Share this:

Like this:

Discover more from Los Angeles Chronic Pain